Gardon J et al., 1997-07: Cohort follow-up of 17,877 people given 150 mcg/kg ivermectin in a Loa loa-endemic area of Cameroon, finding serious reactions including two comas with microfilariae in the CSF. Serious risk rose steeply above 50,000 Loa loa microfilariae/mL.
Two other patients were in coma for 2-3 days, associated with L loa microfilariae in cerebrospinal fluid.
Gardon J et al., 1997-07: Cohort follow-up of 17,877 people given 150 mcg/kg ivermectin in a Loa loa-endemic area of Cameroon, finding serious reactions including two comas with microfilariae in the CSF. Serious risk rose steeply above 50,000 Loa loa microfilariae/mL. C4 Loa loa encephalopathy. Study type: prospective community cohort with 7-day monitoring (mass treatment); N=17,877; Cameroon (Lekie area). Dose: ivermectin 150 mcg/kg single oral dose – the standard approved dose. Comparator: none (prevalence survey of reactions by microfilarial load). Funder: not stated in the PubMed record. Declared conflicts: none in the PubMed record. Numbers from the abstract: 20 patients (0-11%) developed serious reactions without neurological signs but with functional impairment lasting over a week; serious-reaction risk 'very high (odds ratio > 1000) for loads above 50000 microfilariae/mL'.
